Hypoglycemic health benefits of D-psicose
- PMID: 22224918
- DOI: 10.1021/jf204050w
Hypoglycemic health benefits of D-psicose
Abstract
Diabetes is an emerging health problem worldwide. The incidence of type 2 diabetes has dramatically increased and is expected to increase more rapidly in the future. Most patients with type 2 diabetes suffer from obesity and diabetes-related complications, including cardiovascular disease and hepatic steatosis. It has been proposed that simple sugar consumption is one of the major risk factors in the development of diabetes. Hence, the replacement of sugars with a low glycemic response would be an effective strategy to prevent type 2 diabetes. Accumulating evidence demonstrates that D-psicose, which has 70% the sweetness of sucrose and no calories, is a functional sugar exerting several health benefits preventing the development of diabetes. Although D-psicose presents in small amounts in natural products, a recent new technique using biocatalyst sources enables large-scale D-psicose production. More importantly, several clinical and animal studies demonstrated that D-psicose has hypoglycemic, hypolipidemic, and antioxidant activities, which make it an ideal candidate for preventing diabetes and related health concerns. This review will summarize the protective effects of D-psicose against type 2 diabetes and its complications, suggesting its potential benefits as a sucrose substitute.
Similar articles
-
Recent advances on applications and biotechnological production of D-psicose.Appl Microbiol Biotechnol. 2012 Jun;94(6):1461-7. doi: 10.1007/s00253-012-4093-1. Epub 2012 May 10. Appl Microbiol Biotechnol. 2012. PMID: 22569636 Review.
-
D-psicose, a sweet monosaccharide, ameliorate hyperglycemia, and dyslipidemia in C57BL/6J db/db mice.J Food Sci. 2010 Mar;75(2):H49-53. doi: 10.1111/j.1750-3841.2009.01434.x. J Food Sci. 2010. PMID: 20492234
-
Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects.Biosci Biotechnol Biochem. 2010;74(3):510-9. doi: 10.1271/bbb.90707. Epub 2010 Mar 7. Biosci Biotechnol Biochem. 2010. PMID: 20208358 Clinical Trial.
-
Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats.Biochem Biophys Res Commun. 2011 Feb 4;405(1):7-12. doi: 10.1016/j.bbrc.2010.12.091. Epub 2010 Dec 25. Biochem Biophys Res Commun. 2011. PMID: 21187061
-
[Research progress of D-psicose: function and its biosynthesis].Sheng Wu Gong Cheng Xue Bao. 2018 Sep 25;34(9):1419-1431. doi: 10.13345/j.cjb.170526. Sheng Wu Gong Cheng Xue Bao. 2018. PMID: 30255676 Review. Chinese.
Cited by
-
Extraction Methods, Chemical Characterization, and In Vitro Biological Activities of Plinia cauliflora (Mart.) Kausel Peels.Pharmaceuticals (Basel). 2023 Aug 17;16(8):1173. doi: 10.3390/ph16081173. Pharmaceuticals (Basel). 2023. PMID: 37631088 Free PMC article.
-
Impact of broad-spectrum antibiotics on the gut-microbiota-spleen-brain axis.Brain Behav Immun Health. 2022 Dec 17;27:100573. doi: 10.1016/j.bbih.2022.100573. eCollection 2023 Feb. Brain Behav Immun Health. 2022. PMID: 36583066 Free PMC article.
-
Teratogenicity of D-allulose.Toxicol Rep. 2022 Mar 31;9:821-824. doi: 10.1016/j.toxrep.2022.03.028. eCollection 2022. Toxicol Rep. 2022. PMID: 36518485 Free PMC article.
-
In Vitro and In Vivo Antidiabetic Activity, Phenolic Content and Microscopical Characterization of Terfezia claveryi.Molecules. 2022 Jul 28;27(15):4843. doi: 10.3390/molecules27154843. Molecules. 2022. PMID: 35956793 Free PMC article.
-
A pilot study on the effect of D-allulose on postprandial glucose levels in patients with type 2 diabetes mellitus during Ramadan fasting.Diabetol Metab Syndr. 2022 Jun 21;14(1):86. doi: 10.1186/s13098-022-00856-3. Diabetol Metab Syndr. 2022. PMID: 35729673 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
